KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Accounts Payables: 2009-2025

Historic Accounts Payables for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $3.1 billion.

  • Thermo Fisher Scientific's Accounts Payables rose 19.72% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 19.72%. This contributed to the annual value of $3.1 billion for FY2024, which is 7.21% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Accounts Payables is $3.1 billion, which was up 4.70% from $3.0 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Accounts Payables registered a high of $3.4 billion during Q4 2022, and its lowest value of $2.1 billion during Q3 2021.
  • In the last 3 years, Thermo Fisher Scientific's Accounts Payables had a median value of $2.8 billion in 2023 and averaged $2.8 billion.
  • In the last 5 years, Thermo Fisher Scientific's Accounts Payables surged by 51.48% in 2021 and then fell by 15.05% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Accounts Payables (Quarterly) stood at $2.9 billion in 2021, then increased by 17.93% to $3.4 billion in 2022, then dropped by 15.05% to $2.9 billion in 2023, then climbed by 7.21% to $3.1 billion in 2024, then rose by 19.72% to $3.1 billion in 2025.
  • Its Accounts Payables stands at $3.1 billion for Q3 2025, versus $3.0 billion for Q2 2025 and $3.0 billion for Q1 2025.